Prudential Financial’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.61M Buy
244,256
+615
+0.3% +$9.1K ﹤0.01% 1092
2025
Q1
$4.37M Sell
243,641
-725,500
-75% -$13M 0.01% 898
2024
Q4
$16.9M Buy
969,141
+365,200
+60% +$6.36M 0.02% 434
2024
Q3
$8.45M Buy
603,941
+168,300
+39% +$2.35M 0.01% 748
2024
Q2
$3.58M Buy
435,641
+370,380
+568% +$3.04M 0.01% 1072
2024
Q1
$503K Sell
65,261
-23,800
-27% -$183K ﹤0.01% 2171
2023
Q4
$801K Buy
+89,061
New +$801K ﹤0.01% 1934
2022
Q4
Sell
-14,045
Closed -$346K 2703
2022
Q3
$346K Buy
+14,045
New +$346K ﹤0.01% 2248
2021
Q3
Sell
-84,064
Closed -$1.23M 2627
2021
Q2
$1.23M Sell
84,064
-95,038
-53% -$1.39M ﹤0.01% 1733
2021
Q1
$4.47M Sell
179,102
-162,180
-48% -$4.05M 0.01% 1074
2020
Q4
$9.3M Sell
341,282
-103,341
-23% -$2.82M 0.02% 769
2020
Q3
$8.21M Sell
444,623
-79,583
-15% -$1.47M 0.02% 743
2020
Q2
$10.7M Sell
524,206
-6,508
-1% -$133K 0.02% 671
2020
Q1
$7.74M Sell
530,714
-88,610
-14% -$1.29M 0.02% 742
2019
Q4
$8.79M Buy
619,324
+112,051
+22% +$1.59M 0.01% 907
2019
Q3
$5.88M Buy
507,273
+254,174
+100% +$2.95M 0.01% 1041
2019
Q2
$5.08M Buy
253,099
+1,010
+0.4% +$20.3K 0.01% 1149
2019
Q1
$5.71M Buy
252,089
+2,223
+0.9% +$50.3K 0.01% 1085
2018
Q4
$5.65M Sell
249,866
-82,650
-25% -$1.87M 0.01% 1046
2018
Q3
$9.55M Sell
332,516
-38,427
-10% -$1.1M 0.01% 933
2018
Q2
$10.1M Buy
370,943
+155,520
+72% +$4.24M 0.02% 916
2018
Q1
$4.82M Sell
215,423
-11,680
-5% -$261K 0.01% 1188
2017
Q4
$4.79M Buy
227,103
+32,963
+17% +$695K 0.01% 1180
2017
Q3
$4.83M Buy
194,140
+154,170
+386% +$3.84M 0.01% 1167
2017
Q2
$775K Buy
+39,970
New +$775K ﹤0.01% 1923